0000903129false00009031292023-04-272023-04-27

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 27, 2023

 

 

GENTHERM INCORPORATED

(Exact name of Registrant as Specified in Its Charter)

 

 

Michigan			0-21810	95-4318554
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
21680 Haggerty Road
Northville, Michigan				48167
(Address of Principal Executive Offices)				(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (248) 504-0500

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, no par value		THRM		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

---

Item 2.02 Results of Operations and Financial Condition.

On April 27, 2023, Gentherm Incorporated (the “Company”) publicly announced its financial results for the first quarter of 2023. A copy of the Company’s news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On April 27, 2023 at 8:00 a.m. Eastern Time, the Company will host a conference call to discuss the first quarter of 2023 financial results. A copy of the supplemental materials that will be used during the conference call is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
 

The information in Items 2.02 and 7.01 herein and the attached exhibits 99.1 and 99.2 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly stated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit 99.1		Company news release dated April 27, 2023 concerning financial results
Exhibit 99.2		Supplemental materials dated April 27, 2023
Exhibit 104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GENTHERM INCORPORATED
	By:		/s/ Wayne Kauffman
			Wayne Kauffman
			Senior Vice President, General Counsel and Secretary
Date: April 27, 2023

 

---

 

 

Exhibit 99.1

Gentherm Reports 2023 First Quarter Results

Achieved Record Quarterly Revenue

Significantly Outperformed Light Vehicle Production

Secured $480M in New Automotive Awards

Reaffirms 2023 Guidance

NORTHVILLE, Michigan, April 27, 2023 /Global Newswire/ -- Gentherm (NASDAQ:THRM, the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the first quarter ending March 31, 2023.

First Quarter Highlights

 

Phil Eyler, the Company's President and CEO, said “I am proud of the team for delivering record revenue, outperforming actual light vehicle production in our key markets by over 800 basis points organically in Automotive, and improving profitability in the first quarter.”

Eyler continued, “We secured $480 million of new business awards from auto makers around the world, including a breakthrough combined thermal comfort, lumbar and massage system award with Jaguar Land Rover for their new Jaguar BEVs. We also won our first lumbar and massage award with General Motors on a future electric vehicle. The pace of these conquest awards is well ahead of our expectations following the Alfmeier acquisition. Our momentum in the first quarter demonstrates our unique positioning to capitalize on industry megatrends to create a flywheel of profitable growth.”

2023 First Quarter Financial Review

Product revenues for the first quarter of 2023 increased by $96.0 million, or 35.9%, as compared with the prior-year period. Excluding the impact of foreign currency translation, product revenues increased 38.9% year over year.

Automotive revenues increased 36.8% year over year, with revenue increases in all product categories except Automotive Cables. Adjusting for foreign currency translation and the contribution from Alfmeier, organic Automotive revenues increased 14.4% year over year. According to S&P Global’s mid-April report, actual light vehicle production increased by 6.0% in the current year’s first quarter when compared with the first quarter of 2022 in the Company’s key markets of North America, Europe, China, Japan and Korea.

Gentherm Medical revenue increased 11.6% year over year, primarily as a result of the Dacheng acquisition. Adjusting for the contribution from Dacheng and foreign currency translation, Medical revenues decreased 0.3%, primarily due to the reduction in capital spending in U.S. hospitals.

 

---

 

 

See the “Revenues by Product Category” table included below for additional detail.

Gross margin rate decreased to 22.3% in the current-year period, as compared with 24.0% in the prior-year period. The decrease from the prior-year period resulted from the acquired Alfmeier business having a lower gross margin rate relative to the Company’s organic business, wage and material inflation, the negative impact from foreign currency translation, as well as non-automotive electronics inventory charge. These were partially offset by fixed cost leverage from higher unit volume, lower expedited freight costs and cost recoveries from customers.

Net research and development expenses of $25.1 million in the 2023 first quarter increased $4.7 million, or 23.1% over the prior-year period, primarily as a result of the additional expenses from the Alfmeier business and increased investments to support new program wins.

Selling, general and administrative expenses of $37.0 million in the 2023 first quarter increased $7.7 million, or 26.4%, versus the prior-year period. The year-over-year increase was primarily driven by additional expenses from the acquired businesses and higher compensation expenses.

Acquisition and integration expenses of $1.6 million in the current-year period were $1.6 million lower than the prior-year period as a result of reduced expenses associated with the Alfmeier acquisition. Restructuring expenses of $1.3 million in the current-year period as compared to $0.2 million in the prior-year period.

As described more fully in the “Reconciliation of Net Income to Adjusted EBITDA” table included below, the Company recorded Adjusted EBITDA of $41.5 million in the 2023 first quarter compared with $29.8 million in the prior-year period, an increase of $11.7 million or 39.4%.

Income tax expense in the 2023 first quarter was $3.7 million, as compared with $4.3 million in the prior-year period. The effective tax rate was 32% in the 2023 first quarter.

GAAP diluted earnings per share for the first quarter of 2023 was $0.24 compared with $0.35 for the prior-year period. Adjusted diluted earnings per share, excluding unrealized currency loss (gain), non-cash purchase accounting impact, non-automotive electronics inventory charge, acquisition expenses, and restructuring expenses (see table herein), was $0.49. Adjusted diluted earnings per share in the prior-year period was $0.41.

Guidance

The Company reaffirms its full-year 2023 guidance that was initially provided in its year-end 2022 earnings release on February 22, 2023:

 

 

---

 

 

Conference Call

As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13738086.

A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

A telephonic replay will be available at approximately two hours after the call until 11:59 pm Eastern Time on May 11, 2023. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13738086.

Investor Contact
Yijing Brentano
investors@gentherm.com 
248.308.1702

Media Contact
Melissa Fischer
media@gentherm.com 
248.289.9702

 

About Gentherm

Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.

Forward-Looking Statements

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

 

---

 

 

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

 

 

---

 

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

 

		Three Months Ended March 31,
		2023				2022
Product revenues		$	363,625			$	267,657
Cost of sales			282,495				203,544
Gross margin			81,130				64,113
Operating expenses:
Net research and development expenses			25,145				20,434
Selling, general and administrative expenses			37,042				29,308
Restructuring expenses			1,269				181
Total operating expenses			63,456				49,923
Operating income			17,674				14,190
Interest expense, net			(4,144	)			(569	)
Foreign currency (loss) gain			(2,069	)			2,217
Other income			230				204
Earnings before income tax			11,691				16,042
Income tax expense			3,728				4,295
Net income		$	7,963			$	11,747
Basic earnings per share		$	0.24			$	0.36
Diluted earnings per share		$	0.24			$	0.35
Weighted average number of shares – basic			33,182				33,035
Weighted average number of shares – diluted			33,386				33,377

 

 

 

 

---

 

 

GENTHERM INCORPORATED

REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT

(In thousands)

(Unaudited)

 

		Three Months Ended March 31,
		2023				2022				% Change
Climate Control Seat		$	114,753			$	102,734				11.7	%
Seat Heaters			75,636				68,896				9.8	%
Lumbar and Massage Comfort Solutions (a)			38,738				—				100.0	%
Steering Wheel Heaters			36,347				28,736				26.5	%
Valve Systems (a)			26,994				—				100.0	%
Battery Performance Solutions			20,309				17,613				15.3	%
Automotive Cables			20,220				22,045				(8.3	)%
Electronics			10,970				10,828				1.3	%
Other Automotive			8,725				7,012				24.4	%
Subtotal Automotive segment			352,692				257,864				36.8	%
Medical segment (b)			10,933				9,793				11.6	%
Total Company		$	363,625			$	267,657				35.9	%
Foreign currency translation impact (c)			(8,131	)			—
Total Company, excluding foreign currency translation impact		$	371,756			$	267,657				38.9	%
(a) Represents product revenues from Alfmeier (acquired on August 1, 2022).
(b) Includes product revenues of $1,279 from Dacheng (acquired on July 13, 2022).
(c) Foreign currency translation impacts for the Automotive segment and Medical segment were $(8,021) and $(110), respectively, for the three months ended March 31, 2023.

 

 

---

 

 

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

(In thousands)

(Unaudited)

 

		Three Months Ended March 31,
		2023				2022
Net income		$	7,963			$	11,747
Add back:
Depreciation and amortization			13,445				9,487
Income tax expense			3,728				4,295
Interest expense, net (a)			4,144				569
Adjustments:
Restructuring expense			1,269				181
Unrealized currency loss (gain)			5,865				(2,316	)
Acquisition and integration expenses			1,632				3,214
Non-automotive electronics inventory charge			1,419				—
Non-cash stock-based compensation (b)			2,095				2,789
Other			(50	)			(198	)
Adjusted EBITDA		$	41,510			$	29,768
Product revenues		$	363,625			$	267,657
Adjusted EBITDA %			11.4	%			11.1	%
(a) Includes $699 of interest expense for the three months ended March 31, 2023, related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of $100,000.
(b) Includes operating expenses of $1,758 and $2,673 for the three months ended March 31, 2023 and 2022, respectively.

 

		Three months ended March 31,
		2022
Adjusted EBITDA		$	29,768
Non-cash stock-based compensation			(2,789	)
Adjusted EBITDA as reported in Q1 2022 (1)		$	26,979
Adjusted EBITDA Margin as reported in Q1 2022 (1)			10.1	%
(1) Includes the impact of non-cash stock-based compensation
		Three months ended March 31,
		2022
Adjusted EBITDA		$	29,768
Pro forma EBITDA impact of Alfmeier acquisition			589
Pro forma Adjusted EBITDA		$	30,357
Pro forma Adjusted EBITDA Margin			9.1	%
		Three months ended March 31,
		2022
Product revenues		$	267,657
Pro forma revenue impact of Alfmeier acquisition			66,099
Pro forma product revenues		$	333,756

 

 

---

 

 

Use of Non-GAAP Financial Measures

 

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), Adjusted EBITDA margin, adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”), free cash flow, Net Debt, organic revenue, revenue excluding acquired businesses and foreign currency translation, revenue excluding foreign currency translation, adjusted operating expenses, pro forma product revenues and pro forma Adjusted EBITDA, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock-based compensation expenses, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. Note that in recent prior periods, the Company did not exclude non-cash stock-based compensation expenses in the definition of Adjusted EBITDA. Forward-looking references to Adjusted EBITDA and Adjusted EBITDA margin herein exclude the impact of stock-based compensation as newly defined. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines organic revenue as revenue, excluding revenue from acquired businesses. Note that in recent prior periods, the Company used organic revenue instead to be revenue excluding foreign currency translation (see below). The Company defines revenue excluding acquired businesses and foreign currency translation as revenue, excluding the revenue from acquired businesses and the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates. The Company defines revenue excluding foreign currency translation as revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates. The Company defines adjusted operating expenses as operating expenses excluding impairment of intangible assets and property and equipment, restructuring, related non-cash stock-based compensation, acquisition, integration and divestiture expenses. The Company defines pro forma product revenues as product revenues including the product revenues of Alfmeier as if the acquisition had occurred as of January 1, 2022. The Company defines pro forma Adjusted EBITDA as Adjusted EBITDA, as defined above, including the results of Alfmeier as if the acquisition had occurred as of January 1, 2022. The Company defines pro forma Adjusted EBITDA margin as pro forma Adjusted EBITDA, as defined above, divided by pro forma product revenues.

The Company’s reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated April 27, 2023.

In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not

 

---

 

 

modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income, revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. Such forward-looking non-GAAP measures may differ significantly from the corresponding GAAP measures, due to depreciation and amortization, tax expense, and/or interest expense, some or all of which management has not quantified for the future periods.

 

 

---

 

 

GENTHERM INCORPORATED

ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

(In thousands, except per share data)

(Unaudited)

 

 

		Three Months Ended March 31,
		2023				2022
Net income		$	7,963			$	11,747
Non-cash purchase accounting impact			1,850				1,835
Restructuring expenses			1,269				181
Unrealized currency loss (gain)			5,865				(2,316	)
Acquisition and integration expenses			1,632				3,214
Non-automotive electronics inventory charge			1,419				—
Other			(50	)			(198	)
Tax effect of above			(3,517	)			(736	)
Adjusted net income		$	16,431			$	13,727
Weighted average shares outstanding:
Basic			33,182				33,035
Diluted			33,386				33,377
Earnings per share, as reported:
Basic		$	0.24			$	0.36
Diluted		$	0.24			$	0.35
Adjusted earnings per share:
Basic		$	0.50			$	0.42
Diluted		$	0.49			$	0.41

 

 

 

 

 

 

 

 

---

 

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

 

		March 31, 2023				December 31, 2022
ASSETS
Current Assets:
Cash and cash equivalents		$	166,630			$	153,891
Accounts receivable, net			256,715				247,131
Inventory:
Raw materials			137,829				136,217
Work in process			17,091				17,695
Finished goods			63,543				64,336
Inventory, net			218,463				218,248
Other current assets			69,691				64,597
Total current assets			711,499				683,867
Property and equipment, net			242,143				244,480
Goodwill			120,955				119,774
Other intangible assets, net			72,051				73,933
Operating lease right-of-use assets			31,024				29,945
Deferred income tax assets			73,004				69,840
Other non-current assets			18,070				17,461
Total assets		$	1,268,746			$	1,239,300
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable		$	207,887			$	182,225
Current lease liabilities			8,093				7,143
Current maturities of long-term debt			1,996				2,443
Other current liabilities			88,896				93,814
Total current liabilities			306,872				285,625
Long-term debt, less current maturities			232,558				232,653
Non-current lease liabilities			19,740				20,538
Pension benefit obligation			3,326				3,638
Other non-current liabilities			25,932				24,573
Total liabilities		$	588,428			$	567,027
Shareholders’ equity:
Common Stock:
No par value; 55,000,000 shares authorized 33,126,702 and 33,202,082 issued and outstanding at March 31, 2023 and December 31, 2022, respectively			112,420				122,658
Paid-in capital			5,379				5,447
Accumulated other comprehensive loss			(36,101	)			(46,489	)
Accumulated earnings			598,620				590,657
Total shareholders’ equity			680,318				672,273
Total liabilities and shareholders’ equity		$	1,268,746			$	1,239,300

 

 

---

 

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

		Three Months Ended March 31,
		2023				2022
Operating Activities:
Net income		$	7,963			$	11,747
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization			13,583				9,577
Deferred income taxes			(1,786	)			(778	)
Stock based compensation			2,023				2,279
Loss on disposition of property and equipment			16				107
Provisions for inventory			1,704				747
Other			(44	)			256
Changes in assets and liabilities:			—				—
Accounts receivable, net			(8,237	)			(25,788	)
Inventory			(1,137	)			(18,863	)
Other assets			(6,417	)			(10,716	)
Accounts payable			24,289				34,097
Other liabilities			(6,848	)			(3,349	)
Net cash provided by (used in) operating activities			25,109				(684	)
Investing Activities:
Purchases of property and equipment			(6,294	)			(5,659	)
Proceeds from the sale of property and equipment			17				52
Proceeds from deferred purchase price of factored receivables			3,728				—
Cost of technology investments			—				(350	)
Net cash used in investing activities			(2,549	)			(5,957	)
Financing Activities:
Repayments of debt			(564	)			—
Proceeds from the exercise of Common Stock options			263				569
Taxes withheld and paid on employees' share-based payment awards			(2,667	)			(4,319	)
Cash paid for the repurchase of Common Stock			(9,997	)			—
Net cash used in financing activities			(12,965	)			(3,750	)
Foreign currency effect			3,144				(2,298	)
Net increase (decrease) in cash and cash equivalents			12,739				(12,689	)
Cash and cash equivalents at beginning of period			153,891				190,606
Cash and cash equivalents at end of period		$	166,630			$	177,917
Supplemental disclosure of cash flow information:
Cash paid for taxes		$	5,536			$	3,267
Cash paid for interest			3,235				421

 

 

 

 

 

 

---

Proprietary © Gentherm 2023 2023 First Quarter Results April 27, 2023 Exhibit 99.2

---

Forward-Looking Statement Proprietary © Gentherm 2023 Except for historical information contained herein, statements in this presentation are forward-looking statements that are made by Gentherm Incorporated (the “Company”) pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that address future operating, financial or business performance or strategies or expectations are forward-looking statements. The forward-looking statements included in this presentation are made as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The forward-looking statements are subject to a number of important assumptions, risks, uncertainties and other factors that may cause actual results or performance to differ materially from that expressed or implied by such statements. For a discussion of these risks and uncertainties and other factors, please see the Company’s most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission, including “Risk Factors.” In addition, the business outlook discussed in this presentation does not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.

---

Use of Non-GAAP Financial Measures* Proprietary © Gentherm 2023 In addition to the results reported herein in accordance with GAAP, the Company has provided here or may discuss on the related conference call Adjusted Operating Expense, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EPS, Free Cash Flow, Net Debt, organic revenue, revenue excluding acquired businesses and foreign currency translation, revenue excluding foreign currency translation, and gross margin rate excluding acquired businesses, pro forma product revenues and pro forma Adjusted EBITDA, each a non-GAAP financial measure. Starting in 2023, the Company is excluding the impact of non-cash stock-based compensation from its definition of Adjusted EBITDA and Adjusted EBITDA margin. References to Adjusted EBITDA and Adjusted EBITDA margin for prior periods have been recast to exclude the impact of non-cash stock-based compensation. See the Company’s earnings release dated April 27, 2023, for the definitions of each non-GAAP financial measure, information regarding why the Company utilizes such non-GAAP measures as supplemental measures of performance or liquidity, and their limitations, and for certain reconciliations of GAAP to non-GAAP historical financial measures. * See Appendix for certain reconciliations of GAAP to non-GAAP historical financial measures.

---

Automotive Highlights Proprietary © Gentherm 2023 4 Delivered record revenue; outpacing light vehicle production growth* by over 800 basis points 17 Vehicle launches with 9 OEMs Additional thermal content with several OEMs – foundation for scalable ClimateSense® Multiple CCS® Launches Cadillac XT3, Chevrolet Colorado, Silverado EV, Hyundai Genesis G80, Lincoln Nautilus, Great Wall Mecha Dragon EV, WEY Blue Mountain *In our key markets of North America, Europe, China, Japan and Korea

---

New Automotive Business Awards Proprietary © Gentherm 2023 5 Accelerating adoption of thermal comfort, lumbar and massage solutions with global OEMs $480M in awards in 1Q Steering Wheel Heater awards across 10 OEMs including hands-on-detection enabled heater award with Geely 16 Combined thermal comfort, lumbar and massage full system award with Jaguar Land Rover Multiple CCS® Awards from: BYD | GM | Great Wall | Honda | Subaru Breakthrough Lumbar and Massage award with General Motors Proprietary thin foil battery heater and thermal electric BTM awards with Mercedes Benz

---

Medical Highlights Proprietary © Gentherm 2023 6 Double digit revenue growth 13% Revenue up 13 percent year over year excluding the impact of foreign currency translation 35 new major hospital account expansion in China Replaced competitor productsat University of Cincinnati Medical Center

---

Select Income Statement Data Proprietary © Gentherm 2023 7 2023 2022 Pro forma 2022 (1) Product Revenues $363,625 $267,657 $333,756   Automotive 352,692 257,864 323,963   Medical 10,933 9,793 Gross Margin 81,130 64,113 Gross Margin % 22.3% 24.0% Operating Expenses 63,456  49,923 Operating Income 17,674 14,190 Adjusted EBITDA 41,510 29,768 30,357 Adjusted EBITDA Margin 11.4% 11.1% 9.1% Diluted EPS - As Adjusted $0.49 $0.41 Three Months Ended March 31, (Dollars in thousands, except per share data) (1) Pro forma amounts include the results of Alfmeier as if the acquisition had occurred as of January 1, 2022.

---

Select Balance Sheet Data Proprietary © Gentherm 2023 8 March 31, 2023 December 31, 2022 Cash and Cash Equivalents $166,630 $153,891 Total Assets  1,268,746 1,239,300 Debt 234,554 235,096    Current 1,996 2,443    Non-Current 232,558 232,653 Revolving LOC Availability 266,444 264,904 Total Liquidity 433,074 418,795 (Dollars in thousands)

---

2023 Guidance Proprietary © Gentherm 2023 9 2022 A 2022 Pro forma(4) 2023 E Product Revenue (1)(2) $1.2B $1.3B $1.45B - $1.55B Adjusted EBITDA Margin (1)(2)(3) 11.4% 10.4% 11.5% – 13.5% Effective Tax Rate 36% 28% - 32% Capital Expenditures $40M $46M $60M - $70M Based on the current forecast of customer orders, inflation and pricing recovery, and light vehicle production in the Company’s key markets growing at a low single-digit rate in 2023 versus 2022. The 2023 guidance is based on a full year average exchange rate of $1.05/Euro. Starting in 2023, the company is excluding the impact of non-cash stock-based compensation in its calculation of Adjusted EBITDA Margin. Pro forma amounts include the results of Alfmeier as if the acquisition had occurred as of January 1, 2022. Unaudited pro forma information is provided for illustrative purposes only and should be read in conjunction with the consolidated financial statements to better facilitate the assessment and measurement of the Company's operating performance. Such information is not, and should not be assumed to be, an indication of the actual results of the combined company that would have been achieved or may be achieved in the future. Due to the inherent difficulty of forecasting the timing and amount of certain items that would impact net income margin, such as foreign currency gains and losses, we are unable to reasonably estimate net income margin, the GAAP financial measure most directly comparable to Adjusted EBITDA margin. Accordingly, we are unable to provide a reconciliation of Adjusted EBITDA margin to net income margin with respect to the guidance provided.

---

Appendix Proprietary © Gentherm 2023

---

Reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin Proprietary © Gentherm 2023 11 (Dollars in thousands) 2023 2022 Net Income $7,963 $11,747 Add Back:      Income Tax Expense  3,728 4,295      Interest Expense, net 4,144 569      Depreciation and Amortization  13,445 9,487 Adjustments:      Restructuring Expenses  1,269 181      Unrealized Currency Loss (Gain) 5,865 (2,316)      Acquisition and Integration Expenses 1,632 3,214      Non-Automotive Electronics Inventory Charge 1,419 --      Non-Cash Stock-Based Compensation 2,095 2,789      Other (50) (198) Adjusted EBITDA  $41,510 $29,768 Product Revenues $363,625 $267,657 Net Income Margin 2.2% 4.4% Adjusted EBITDA Margin 11.4% 11.1% Three Months Ended March 31,

---

Reconciliation of Adjusted EPS Proprietary © Gentherm 2023 12 2023 2022 Diluted EPS - As Reported $0.24 $0.35 Acquisition and Integration Expenses 0.05 0.10 Non-Cash Purchase Accounting Impacts 0.06 0.05 Unrealized Currency Loss (Gain)  0.18 (0.07) Restructuring Expenses 0.04 0.01 Non-Automotive Electronics Inventory Charge 0.04 -- Other -- (0.01) Tax Effect of Above (0.11)   (0.02)  Rounding (0.01) -- Diluted EPS - As Adjusted $0.49 $0.41 Three Months Ended March 31,